lobbying_activities: 1585830

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1585830	fb8bf7e4-5cb6-4dc3-9eae-88a616835f55	Q3	BROWN RUDNICK LLP	287895	AMNEAL PHARMACEUTICALS	2014	third_quarter	PHA	Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94); P.L. 110 -85 relating to Risk Evaluation and Mitigation Strategy programs.	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2014-10-14T15:57:55.680000-04:00